REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs CTS Q1 2026 Earnings Strong EPS Beat of 18 Drives Positive Stock Reaction COCH Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress Though Revenue Absence Raises Questions JNJ Q1 2026 Earnings Narrow EPS Beat Signals Operational Resilience Amid Mixed Market Sentiment Sera Prognostics Q1 2026 Earnings EPS In Line with Estimates as Stock Rises 15 SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues